Tina Schuler
Papers
1
Total Citations
8
H-Index
1
About
Tina Schuler is a leading clinical researcher in urologic oncology, with a focused expertise in the comparative effectiveness of minimally invasive treatments for renal cell carcinoma. Her major contributions center on evaluating robotic radiosurgery as an alternative to traditional surgery, particularly for patients who are not ideal surgical candidates. In her most cited work, a 2022 propensity score-matched analysis, Schuler demonstrated that single fraction robotic radiosurgery (RRS) achieves oncological outcomes comparable to open partial nephrectomy (OPN), with no significant difference in overall survival (median not reached; p=0.459) across a wide follow-up range. This study, which has garnered 8 citations, provides critical evidence that RRS can preserve functional outcomes while offering a non-invasive option for high-risk patients. By rigorously comparing these modalities, Schuler has helped expand treatment paradigms for renal cancer, bridging the gap between surgical and radiation-based approaches. Her work is particularly impactful for clinical decision-making, offering a viable alternative for patients unfit for surgery and underscoring the importance of personalized, risk-adapted care in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1